Defective decatenation checkpoint function is a common feature of melanoma

21Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A hallmark of cancer is genomic instability that is considered to provide the adaptive capacity of cancers to thrive under conditions in which the normal precursors would not survive. Recent genomic analysis has revealed a very high degree of genomic instability in melanomas, although the mechanism by which this instability arises is not known. Here we report that a high proportion (68%) of melanoma cell lines are either partially (40%) or severely (28%) compromised for the G 2 phase decatenation checkpoint that normally functions to ensure that the sister chromatids are able to separate correctly during mitosis. The consequence of this loss of checkpoint function is a severely reduced ability to partition the replicated genome in mitosis and thereby increase genomic instability. We also demonstrate that decatenation is dependent on both TopoIIα and β isoforms. The high incidence of decatenation checkpoint defect is likely to be a major contributor to the high level of genomic instability found in melanomas. © 2014 The Society for Investigative Dermatology.

Cite

CITATION STYLE

APA

Brooks, K., Chia, K. M., Spoerri, L., Mukhopadhyay, P., Wigan, M., Stark, M., … Gabrielli, B. (2014). Defective decatenation checkpoint function is a common feature of melanoma. Journal of Investigative Dermatology, 134(1), 150–158. https://doi.org/10.1038/jid.2013.264

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free